Company page

Co-diagnostics, Inc.

Co-Diagnostics, Inc. is a public company traded under the ticker CODX in the American market. The company has a market capitalization of approximately $11 million. Co-Diagnostics focuses on developing molecular diagnostics for various diseases, leveraging its proprietary technology to enhance testing capabilities.